News & Events
-
Three Moments That Defined the 2026 Targeted Therapies of Lung Cancer Conference
The 2026 Targeted Therapies of Lung Cancer Meeting brought together leading clinicians, researchers, and patient advocates to discuss the latest advances shaping the future of lung cancer care. Hosted...
-
Progress in Cancer Care: What the Numbers Tell Us About Lung Cancer
Every January, the American Cancer Society releases a Cancer Facts & Figures report. It provides a clear view of where we stand in addressing cancer. The 2026 report brings both... -
Why Immunotherapy Isn’t Perfect & How Scientists Are Working to Fix It
The human immune system is an intricate web of checks and balances that usually excels at detecting and destroying foreign invaders, such as bacteria and viruses, while protecting... -
New Horizons in Immunotherapy: Lung Cancer Highlights from the 2025 SITC Meeting
The Society for Immunotherapy of Cancer (SITC) celebrated their 40th anniversary at their annual meeting in National Harbor, Maryland from November 5-9, 2025. The meeting focused... -
The Future of Lung Cancer Starts Here
For more than two decades, LUNGevity Foundation has been a leader in advancing lung cancer research. Since 2002, we have invested $55+ million in more than 200 research projects... -
LUNGevity Foundation Invests $1.2 Million to Fuel Next Generation of Lung Cancer Research
LUNGevity Foundation announced $1.2 million in research awards that are designed to strengthen the lung cancer workforce and accelerate progress across the lung cancer continuum... -
KRAS Virtual Meetup
Join us the 3rd Wednesday of every month to c onnect with others who share common experiences and build your community. After registering, you will receive a confirmation email... -
Celebrating Progress in Lung Cancer: From Detection to Survivorship
Over the past twenty years, lung cancer research and care have entered a new era. One filled with hope, innovation, and progress that is transforming what it means to face a lung... -
New Insights in Treating Metastatic Lung Cancer from WCLC 2025
For people with advanced or metastatic non-small cell lung cancer (NSCLC), the treatment landscape has changed dramatically in recent years. Researchers are learning how to... -
2025 ASCO: Highlights of Lung Cancer Research
The annual meeting of the American Society of Clinical Oncology (ASCO) once again brought together nearly 50,000 members of the oncology community. From May 30 – June 2...
The clinicopathologic characteristics and outcomes of uncommon KRAS mutations in patients with non-small cell lung cancer
The clinicopathologic characteristics and outcomes of uncommon KRAS mutations in patients with non-small cell lung cancer
Durable response to sotorasib-based combination therapy in advanced lung adenocarcinoma harboring KRAS G12C and STK11 mutations: a case report
Durable response to sotorasib-based combination therapy in advanced lung adenocarcinoma harboring KRAS G12C and STK11 mutations: a case report
Investigators from Tianjin Medical University Target Personalized Medicine (A Ct Imaging-based Deep Learning Model for Predicting Egfr and Kras Mutations In Non-small Cell Lung Cancer:...
Investigators from Tianjin Medical University Target Personalized Medicine (A Ct Imaging-based Deep Learning Model for Predicting Egfr and Kras Mutations In Non-small Cell Lung Cancer:...
Selinexor and Docetaxel Indicate Promise in KRAS-Mutant NSCLC
Cetuximab Boosts KRAS G12C Inhibitors in Lung Cancer
UK's NICE Does Not Recommend Lumakras for KRAS G12C-Mutant NSCLC, Asks for More Data
和誉医药口服小分子KRAS G12D抑制剂ABSK141完成首例患者给药
Sintilimab plus anlotinib in later-line treatment of advanced KRAS-mutant NSCLC: a multicenter, retrospective case series
Sintilimab plus anlotinib in later-line treatment of advanced KRAS-mutant NSCLC: a multicenter, retrospective case series
Findings from University of Malakand Provide New Insights into Computational Biophysics and Chemistry (Transfiguring Novel Marine Natural Product As Oncogenic Kras G12c Mutant Inhibitors Via...
Findings from University of Malakand Provide New Insights into Computational Biophysics and Chemistry (Transfiguring Novel Marine Natural Product As Oncogenic Kras G12c Mutant Inhibitors Via...